Hydromer, Inc. (OTCMKTS:HYDI) specializes in the development and commercialization of advanced polymer technologies and coating solutions for diverse industries. The company’s core expertise lies in formulating thin-film coatings that enhance the surface properties of medical devices, personal care products, and consumer goods. By leveraging proprietary hydrophilic, hydrophobic, and drug-eluting chemistries, Hydromer delivers tailored solutions designed to improve lubricity, biocompatibility, controlled release, and moisture resistance.
In the healthcare sector, Hydromer’s coatings are applied to catheters, guide wires, stents, and other minimally invasive surgical tools to reduce friction and the risk of thrombosis. The company also offers pharmaceutical coatings that provide precise drug delivery profiles and extended-release capabilities for oral dosage forms. Outside of medical applications, Hydromer serves customers in personal care with coatings that enhance product performance in skincare, haircare, and cosmetics. Additional markets include industrial packaging, where barrier and anti-corrosion coatings extend the shelf life and durability of sensitive goods.
Founded in the early 1970s and headquartered in South Plainfield, New Jersey, Hydromer operates research and manufacturing facilities in the United States and collaborates with contract manufacturers worldwide. The company’s global reach is bolstered by strategic partnerships and licensing agreements in Europe, Asia, and Latin America, enabling it to meet regional regulatory requirements and customer specifications. Over the years, Hydromer has secured multiple patents for its innovative polymer coating systems and has been recognized for its contributions to medical device technology and pharmaceutical development.
Under the leadership of President and Chief Executive Officer Michael R. Fiorentino and Chief Technology Officer Dr. Anita Desai, Hydromer continues to invest in R&D to expand its product pipeline and address emerging industry needs. The management team’s focus on quality, regulatory compliance, and customer collaboration supports long-term growth initiatives across key end markets. As Hydromer advances its technology portfolio, it aims to capitalize on trends in minimally invasive procedures, personalized medicine, and sustainable packaging solutions.
AI Generated. May Contain Errors.
Free HYDI Stock Alerts